Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gender Specificity of Furosemide Effects
NCT01156220Phase 4Withdrawn
- Sponsor
- University Medical Center Hamburg-Eppendorf
- Start
- Jan 2012
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of furosemide in edema and hypertension (HTN) (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoints: Area Under the Curve (0-24h) and Urinary Sodium Excretion. Planned start Jan 2012; status: withdrawn.
02
Drugs
furosemide
03
Conditions
edemahypertension (HTN)
Beyond the preview
Go deeper on NCT01156220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01156220.